James is a lecturer in the Department for Health at the University of Bath and is leading a programme of research that examines the immunology of cancer and viral infection in the context of lifestyle factors and ageing. Prior to taking up his position at the University of Bath in 2013, James undertook a PhD between 2007-2010 in the School of Sport, Exercise and Rehabilitation Sciences at the University of Birmingham, UK. His thesis covered topics related to the biochemistry and immunology of ageing and exercise. Following his PhD, James remained in Birmingham to undertake three years of post-doctoral training in the School of Immunity and Infection and the School of Cancer Sciences. During this time, James characterised immune responses to novel therapeutic targets for treating blood cancers, and conducted research towards producing a prophylactic vaccine to prevent glandular fever and cancers caused by Epstein-Barr Virus.
A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: A phase I trial in UK patients with EBV-positive cancer